Pharmafile Logo

MEDSCAPE’S NEW AGE OF CERTAINTY FOR CME

- PMLiVE

The CME industry is changing. More than ever, activities need to be prioritized and measured to increase their impact on patient outcomes. Improving patient outcomes is the core objective for education providers, and there is a need to systematically review how activities are planned, evaluated, and resourced to maximize their impact in order to obtain the necessary investment.

(You can also download and save this article here)

But can the impact of continuing medical education be guaranteed?

Medscape Education knows it can. As the leading provider of continuing medical education, Medscape is transforming CME in 2024 by setting a new standard for program development, distribution, and impact measurement.

Introducing Next-Generation Return-On-Education Guarantees

“We have always relied on data to guide our decisions, but now we are leveraging new technologies and methodologies to become an impact-driven organization. By evolving our strategies and approaches in audience engagement, outcome measurement, precision targeting, content development, and instructional design we can achieve greater educational precision and impact. These advancements are enabling us to accurately identify and engage with our target audiences, measure the impact of our efforts, and design content that effectively meets the needs of our members. This focus on precision and impact is allowing us to create greater value for our stakeholders and set a new industry standard where precision and impact from education can be guaranteed.” Katie Lucero PhD Chief Impact Officer, Medscape Education

Medscape’s advanced data-driven approach is poised to mark an inflection point for the industry, catalyzing meaningful change through innovative solutions informed by unique insights from its vast membership.

“We have the benefit of 29 years of experience and the power of an incredibly talented team that allows us to analyze vast amounts of data with a high level of expertise. As we start to conceptualize an education activity, we look at historical information and apply predictive analytics to set achievable benchmarks. Who will this program reach? What will they learn? How will it impact the desired outcomes? These questions, and more, reflect the strategic approach we take to educational design – start with the end in mind. We then take our experience and the data to create precise programs to a very high standard. We pay attention to every fine detail regarding the target audience, how we communicate with
them, the design and the delivery. By doing this, we’re able to know with certainty that our impact goals and educational mission will be achieved. This is a tried and tested process which we are now ready to share with the industry and act as catalyst for positive change.”

After careful development that stays true to the vision of the education that was conceived during the planning stages, Medscape is able to monitor if the right learners are engaging with the education. If they aren’t, Medscape has the flexibility and capability to make adjustments to ensure the programs reach the clinicians that need it. Medscape has a tool called PULSE – the Precision, User, Learning and Segmentation Engine. This is an industry leading tool that allows for the identification and reach of learners in a very precise way, leveraging an omnichannel approach so the education is there exactly when the clinician is most primed to learn.

- PMLiVE

Through the careful development process and the power of PULSE, Medscape education programs are able to reach the precise target audience and impact goals that have been set.

“There are different impact goals for different pieces of education. In some cases, the most important thing is to put the information into the hands of as many clinicians as possible. In other cases, a very specific subset of clinicians may need to be reached, while in still others, there might be a specific action or clinical behavior that needs to be implemented in a precise audience of clinicians. We not only have the ability to identify and reach those goals, we will use data to identify what our benchmarks should be and guarantee them before the program goes live.”

Medscape’s impact-forward transformation is allowing for greater precision of education.

- PMLiVE

(You can also download and save this article here)

- PMLiVE

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.

From Genetic Puzzles to Precision Therapeutics

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...

Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series

Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...

What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?

Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...

“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards

Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...